These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 19700413)

  • 1. A multicentre, randomised, double-blind, placebo controlled study of cryotherapy versus cryotherapy and podophyllotoxin cream as treatment for external anogenital warts.
    Gilson RJ; Ross J; Maw R; Rowen D; Sonnex C; Lacey CJ
    Sex Transm Infect; 2009 Dec; 85(7):514-9. PubMed ID: 19700413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 5-fluorouracil has no additional benefit in treating common warts with cryotherapy: a single-centre, double-blind, randomized, placebo-controlled trial.
    Luk NM; Tang WY; Tang NL; Chan SW; Wong JK; Hon KL; Lo KK
    Clin Exp Dermatol; 2006 May; 31(3):394-7. PubMed ID: 16681586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of endoscopic therapy of anal canal condylomata acuminata with podophyllotoxin.
    Tzathas C; Stavrianeas NG; Triantafyllou K; Triantafyllou G; Ladas SD
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):364-7. PubMed ID: 17309460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts.
    Bonnez W; Elswick RK; Bailey-Farchione A; Hallahan D; Bell R; Isenberg R; Stoler MH; Reichman RC
    Am J Med; 1994 May; 96(5):420-5. PubMed ID: 8192173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women.
    Greenberg MD; Rutledge LH; Reid R; Berman NR; Precop SL; Elswick RK
    Obstet Gynecol; 1991 May; 77(5):735-9. PubMed ID: 2014088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Efficacy, Safety, and Tolerability of 3 Dose Regimens of Topical Sodium Nitrite With Citric Acid in Patients With Anogenital Warts: A Randomized Clinical Trial.
    Ormerod AD; van Voorst Vader PC; Majewski S; Vanscheidt W; Benjamin N; van der Meijden W
    JAMA Dermatol; 2015 Aug; 151(8):854-61. PubMed ID: 25922903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EVerT: cryotherapy versus salicylic acid for the treatment of verrucae--a randomised controlled trial.
    Cockayne S; Curran M; Denby G; Hashmi F; Hewitt C; Hicks K; Jayakody S; Kang'ombe A; McIntosh C; McLarnon N; Stamuli E; Thomas K; Turner G; Torgerson D; Watt I;
    Health Technol Assess; 2011 Sep; 15(32):1-170. PubMed ID: 21899812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts.
    Lacey CJ; Goodall RL; Tennvall GR; Maw R; Kinghorn GR; Fisk PG; Barton S; Byren I;
    Sex Transm Infect; 2003 Aug; 79(4):270-5. PubMed ID: 12902571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short, 8-week course of imiquimod 5% cream versus podophyllotoxin in the treatment of anogenital warts: A retrospective comparative cohort study.
    Nicolaidou E; Kanelleas A; Nikolakopoulos S; Bezrodnii G; Nearchou E; Gerodimou M; Papadopoulou-Skordou E; Paparizos V; Rigopoulos D
    Indian J Dermatol Venereol Leprol; 2021; 87(5):666-670. PubMed ID: 31650979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
    Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
    Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study.
    Handley JM; Horner T; Maw RD; Lawther H; Dinsmore WW
    Genitourin Med; 1991 Aug; 67(4):297-302. PubMed ID: 1916791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryotherapy for anogenital warts: factors affecting therapeutic response.
    Rasi A; Soltani-Arabshahi R; Khatami A
    Dermatol Online J; 2007 Oct; 13(4):2. PubMed ID: 18318999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of condylomata acuminata in women. A placebo-controlled, double-blind study.
    Syed TA; Lundin S; Ahmad SA
    Dermatology; 1994; 189(2):142-5. PubMed ID: 8075441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of recurrent condyloma acuminatum with solid lipid nanoparticle gel containing podophyllotoxin: a randomized double-blinded, controlled clinical trial].
    Xie FM; Zeng K; Chen ZL; Li GF; Lin ZF; Zhu XL; Sun LD
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):657-9. PubMed ID: 17545082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral inosiplex in the treatment of cervical condylomata acuminata: a randomised placebo-controlled trial.
    Georgala S; Katoulis AC; Befon A; Georgala C; Rigopoulos D
    BJOG; 2006 Sep; 113(9):1088-91. PubMed ID: 16956341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.